1. Home
  2. MLEC vs GDTC Comparison

MLEC vs GDTC Comparison

Compare MLEC & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLEC
  • GDTC
  • Stock Information
  • Founded
  • MLEC 2008
  • GDTC 2018
  • Country
  • MLEC Luxembourg
  • GDTC Singapore
  • Employees
  • MLEC N/A
  • GDTC N/A
  • Industry
  • MLEC Blank Checks
  • GDTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • MLEC Finance
  • GDTC Health Care
  • Exchange
  • MLEC Nasdaq
  • GDTC Nasdaq
  • Market Cap
  • MLEC 23.9M
  • GDTC 29.4M
  • IPO Year
  • MLEC N/A
  • GDTC 2023
  • Fundamental
  • Price
  • MLEC $0.56
  • GDTC $2.65
  • Analyst Decision
  • MLEC
  • GDTC Buy
  • Analyst Count
  • MLEC 0
  • GDTC 1
  • Target Price
  • MLEC N/A
  • GDTC $5.00
  • AVG Volume (30 Days)
  • MLEC 10.4K
  • GDTC 25.0K
  • Earning Date
  • MLEC 03-12-2025
  • GDTC 01-01-0001
  • Dividend Yield
  • MLEC N/A
  • GDTC N/A
  • EPS Growth
  • MLEC N/A
  • GDTC N/A
  • EPS
  • MLEC N/A
  • GDTC N/A
  • Revenue
  • MLEC $5,625,124.00
  • GDTC $330,254.00
  • Revenue This Year
  • MLEC $20.42
  • GDTC $14.71
  • Revenue Next Year
  • MLEC $30.00
  • GDTC N/A
  • P/E Ratio
  • MLEC N/A
  • GDTC N/A
  • Revenue Growth
  • MLEC 521.53
  • GDTC N/A
  • 52 Week Low
  • MLEC $0.55
  • GDTC $1.20
  • 52 Week High
  • MLEC $3.25
  • GDTC $4.05
  • Technical
  • Relative Strength Index (RSI)
  • MLEC 24.92
  • GDTC 49.22
  • Support Level
  • MLEC $0.71
  • GDTC $2.55
  • Resistance Level
  • MLEC $0.78
  • GDTC $2.94
  • Average True Range (ATR)
  • MLEC 0.05
  • GDTC 0.22
  • MACD
  • MLEC -0.02
  • GDTC 0.01
  • Stochastic Oscillator
  • MLEC 3.14
  • GDTC 53.23

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: